165 related articles for article (PubMed ID: 9811834)
1. Topoisomerase II-mediated site-directed alkylation of DNA by psorospermin and its use in mapping other topoisomerase II poison binding sites.
Kwok Y; Zeng Q; Hurley LH
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13531-6. PubMed ID: 9811834
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase II site-directed alkylation of DNA by psorospermin and its effect on topoisomerase II-mediated DNA cleavage.
Kwok Y; Hurley LH
J Biol Chem; 1998 Dec; 273(49):33020-6. PubMed ID: 9830055
[TBL] [Abstract][Full Text] [Related]
3. Determination of the importance of the stereochemistry of psorospermin in topoisomerase II-induced alkylation of DNA and in vitro and in vivo biological activity.
Fellows IM; Schwaebe M; Dexheimer TS; Vankayalapati H; Gleason-Guzman M; Whitten JP; Hurley LH
Mol Cancer Ther; 2005 Nov; 4(11):1729-39. PubMed ID: 16275994
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of psorospermin/quinobenzoxazine hybrids as structurally novel antitumor agents.
Kim MY; Na Y; Vankayalapati H; Gleason-Guzman M; Hurley LH
J Med Chem; 2003 Jul; 46(14):2958-72. PubMed ID: 12825936
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into a quinolone-topoisomerase II-DNA complex. Further evidence for a 2:2 quinobenzoxazine-mg2+ self-assembly model formed in the presence of topoisomerase ii.
Kwok Y; Zeng Q; Hurley LH
J Biol Chem; 1999 Jun; 274(24):17226-35. PubMed ID: 10358081
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of the antileukemic xanthone psorospermin: DNA strand breaks, abasic sites, and protein-DNA cross-links.
Permana PA; Ho DK; Cassady JM; Snapka RM
Cancer Res; 1994 Jun; 54(12):3191-5. PubMed ID: 8205539
[TBL] [Abstract][Full Text] [Related]
7. Antitumor psoropermum xanthones and sarcomelicope acridones: privileged structures implied in DNA alkylation.
Nguyen HT; Lallemand MC; Boutefnouchet S; Michel S; Tillequin F
J Nat Prod; 2009 Mar; 72(3):527-39. PubMed ID: 19191562
[TBL] [Abstract][Full Text] [Related]
8. Apurinic sites are position-specific topoisomerase II poisons.
Kingma PS; Osheroff N
J Biol Chem; 1997 Jan; 272(2):1148-55. PubMed ID: 8995415
[TBL] [Abstract][Full Text] [Related]
9. Conformationally restricted analogues of psorospermin: design, synthesis, and bioactivity of natural-product-related bisfuranoxanthones.
Heald RA; Dexheimer TS; Vankayalapati H; Siddiqui-Jain A; Szabo LZ; Gleason-Guzman MC; Hurley LH
J Med Chem; 2005 Apr; 48(8):2993-3004. PubMed ID: 15828838
[TBL] [Abstract][Full Text] [Related]
10. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
11. The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage.
Gatto B; Richter S; Moro S; Capranico G; Palumbo M
Nucleic Acids Res; 2001 Oct; 29(20):4224-30. PubMed ID: 11600711
[TBL] [Abstract][Full Text] [Related]
12. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
13. Analysis of topoisomerase II-mediated DNA cleavage in the 5'-region of the Drosophila hsp70 gene. Identification of a novel half-site DNA substrate for topoisomerase II cleavage.
Kroeger PE; Osheroff N; Rowe TC
J Biol Chem; 1993 Aug; 268(22):16449-57. PubMed ID: 8393863
[TBL] [Abstract][Full Text] [Related]
14. Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons.
Borgnetto ME; Tinelli S; Carminati L; Capranico G
J Mol Biol; 1999 Jan; 285(2):545-54. PubMed ID: 9878428
[TBL] [Abstract][Full Text] [Related]
15. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons.
Kingma PS; Corbett AH; Burcham PC; Marnett LJ; Osheroff N
J Biol Chem; 1995 Sep; 270(37):21441-4. PubMed ID: 7665552
[TBL] [Abstract][Full Text] [Related]
16. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
[TBL] [Abstract][Full Text] [Related]
17. Psorospermin structural requirements for P-glycoprotein resistance reversal.
Carey SS; Gleason-Guzman M; Gokhale V; Hurley LH
Mol Cancer Ther; 2008 Nov; 7(11):3617-23. PubMed ID: 19001443
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.
Kingma PS; Greider CA; Osheroff N
Biochemistry; 1997 May; 36(20):5934-9. PubMed ID: 9166762
[TBL] [Abstract][Full Text] [Related]
19. Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.
Hawtin RE; Stockett DE; Byl JA; McDowell RS; Nguyen T; Arkin MR; Conroy A; Yang W; Osheroff N; Fox JA
PLoS One; 2010 Apr; 5(4):e10186. PubMed ID: 20419121
[TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerase II cleavage of telomeres in vitro and in vivo.
Yoon HJ; Choi IY; Kang MR; Kim SS; Muller MT; Spitzner JR; Chung IK
Biochim Biophys Acta; 1998 Jan; 1395(1):110-20. PubMed ID: 9434158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
